Profile data is unavailable for this security.
About the company
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors. The Company operates through its wholly owned subsidiaries, 3D Bio-Tissues Limited (3DBT), Lab Grown Leather Limited (LGL), Kerato Limited (Kerato), and BSF Enterprise (Hong Kong) Limited (BSF HK). 3DBT is a tissue engineering company developing processes and tools for others to create functional tissues from a range of cell types. This includes a platform for generating structured tissues as well as media supplements that can accelerate and increase cell performance. Kerato utilizes multi-patented technology with expertise in tissue engineering and biomaterials to develop bio-equivalent corneal tissue.
- Revenue in GBP (TTM)52.84k
- Net income in GBP-1.11m
- Incorporated2018
- Employees10.00
- LocationBSF Enterprise PLCGround Floor, 31 Old Burlington StreetLONDON W1S 3ASUnited KingdomGBR
- Phone+44 203 283 4590
- Websitehttps://bsfenterprise.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kanabo Group PLC | 1.14m | -8.18m | 1.42m | 17.00 | -- | 0.2402 | -- | 1.25 | -0.013 | -0.013 | 0.0018 | 0.0094 | 0.1054 | 16.28 | 43.85 | 67,058.82 | -75.70 | -75.83 | -81.16 | -83.33 | 7.89 | -- | -718.33 | -1,267.35 | 2.72 | -63.43 | 0.0337 | -- | 48.42 | -- | -16.26 | -- | -- | -- |
| BSF Enterprise PLC | 52.84k | -1.11m | 2.57m | 10.00 | -- | 0.9447 | -- | 48.59 | -0.0093 | -0.0093 | 0.0004 | 0.0212 | 0.0163 | 0.9496 | 4.07 | 5,284.00 | -34.25 | -35.35 | -37.51 | -38.06 | -34.37 | -- | -2,107.34 | -4,267.99 | 1.38 | -710.58 | 0.00 | -- | -8.61 | -- | 33.41 | -- | -- | -- |
| Nuformix PLC | 0.00 | -652.59k | 4.64m | 3.00 | -- | 5.92 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -65.61 | -- | -88.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 82.08 | -- | -- | -- |
| CRISM' Therapeutics Corp | 25.00k | -1.49m | 7.24m | 0.00 | -- | 4.20 | -- | 289.72 | -0.0458 | -0.0469 | 0.0008 | 0.0333 | 0.012 | -- | 0.0305 | -- | -71.61 | -9.33 | -88.05 | -9.68 | 72.00 | -- | -5,952.00 | -32,053.62 | -- | -- | 0.00 | -- | -- | -- | 69.17 | -- | -41.03 | -- |
| Oxford Biodynamics PLC | 1.10m | -11.15m | 12.23m | 44.00 | -- | 5.00 | -- | 11.17 | -0.0096 | -0.0096 | 0.0008 | 0.0006 | 0.1085 | 2.22 | 1.21 | -- | -110.46 | -70.62 | -148.46 | -89.03 | 47.67 | -- | -1,018.54 | -1,715.57 | 0.8005 | -30.88 | 0.8208 | -- | 72.17 | 19.15 | 3.58 | -- | -11.79 | -- |
| Probiotix Health PLC | 2.22m | -736.00k | 12.26m | 4.00 | -- | 6.85 | -- | 5.52 | -0.005 | -0.005 | 0.0146 | 0.0113 | 1.05 | 18.57 | 3.01 | 555,250.00 | -34.67 | -21.03 | -46.17 | -27.30 | 53.17 | 54.10 | -33.14 | -26.58 | 3.99 | -- | 0.00 | -- | 12.55 | 36.47 | -13.39 | -- | -41.50 | -- |
